Wave Life Sciences
87 hedge funds and large institutions have $246M invested in Wave Life Sciences in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 28 reducing their positions, and 31 closing their positions.
77% more call options, than puts
Call options by funds: $1.49M | Put options by funds: $839K
14% more capital invested
Capital invested by funds: $215M → $246M (+$31M)
4% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 28
4.5% less ownership
Funds ownership: 78.13% → 73.63% (-4.5%)
15% less funds holding
Funds holding: 102 → 87 (-15)
48% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$8.66M |
| 2 |
Millennium Management
New York
|
+$5.01M |
| 3 |
6CM
683 Capital Management
New York
|
+$3.27M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.55M |
| 5 |
Renaissance Technologies
New York
|
+$569K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$7.11M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.76M |
| 3 |
JP Morgan Chase
New York
|
-$2.43M |
| 4 |
Morgan Stanley
New York
|
-$2.34M |
| 5 |
ACM
Altium Capital Management
New York
|
-$2.24M |
WVE Hedge Fund Activity: Q2 2021 in Review
87 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2021, worth a combined $246M — up 14% from $215M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of WVE and 16 opened new positions — a net loss of 15 holders — while 28 trimmed existing stakes and 29 added.
The largest buyer was Deerfield Management, adding an estimated $8.66M. The largest seller was Nantahala Capital Management, cutting an estimated $7.11M.
- 87 institutional investors held Wave Life Sciences (WVE) as of Q2 2021, down from 102 in Q1 2021.
- Funds reported $246M of Wave Life Sciences stock for Q2 2021, up 14% quarter-over-quarter.
- 16 funds opened new Wave Life Sciences positions in Q2 2021 and 31 closed out, a net change of -15 holders.
- The largest Wave Life Sciences buyer in Q2 2021 was Deerfield Management, an estimated $8.66M added.
- The largest Wave Life Sciences seller in Q2 2021 was Nantahala Capital Management, an estimated $7.11M sold.
Based on aggregated 13F filings for Q2 2021.